Literature DB >> 22572506

Two cases of Pompe's disease: case report and review of literature.

A Jegadeeswari1, V Amuthan, R A Janarthanan, S Murugan, S Balasubramanian.   

Abstract

Glycogen storage disease type II (also called Pompe's disease or acid maltase deficiency) is an autosomal recessive metabolic disorder which causes an accumulation of glycogen in the lysosomes due to deficiency of the lysosomal acid alpha-glucosidase enzyme. It is the only glycogen storage disease with a defect in lysosomal metabolism, and the first glycogen storage disease to be identified in 1932. The build-up of glycogen causes progressive muscle weakness (myopathy) throughout the body and affects various body tissues, particularly in the heart, skeletal muscles, liver, and nervous system. We are presenting two cases of infantile form of Pompe's disease with secondary hypertrophic cardiomyopathy (CMP). The first case was a 1-year-old female child who presented with Ross Class III heart failure (HF) of 3 months duration. Echocardiography (ECHO) showed concentric left ventricular (LV) hypertrophy, with the posterobasal segment more hypertrophic than the inter-ventricular septum and moderate pericardial effusion. The second case was a 2-month-old male child who presented with Ross Class II HF. His ECHO showed eccentric hypertrophy of the posterobasal left ventricle, with thickening of the mitral valve leaflets and the chordae with Grade I mitral regurgitation (MR). Both children were diagnosed to have Pompe's disease by blood alpha-glucosidase assay.
Copyright © 2012 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22572506      PMCID: PMC3861064          DOI: 10.1016/S0019-4832(12)60067-4

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  9 in total

1.  Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease.

Authors:  K Umapathysivam; J J Hopwood; P J Meikle
Journal:  Clin Chem       Date:  2001-08       Impact factor: 8.327

2.  Identification of two subtypes of infantile acid maltase deficiency.

Authors:  A E Slonim; L Bulone; S Ritz; T Goldberg; A Chen; F Martiniuk
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

3.  A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease.

Authors:  Priya S Kishnani; Wuh-Liang Hwu; Hanna Mandel; Marc Nicolino; Florence Yong; Deyanira Corzo
Journal:  J Pediatr       Date:  2006-05       Impact factor: 4.406

4.  Echocardiographic findings in Pompe's disease with left ventricular obstruction.

Authors:  Y Shapir; N Roguin
Journal:  Clin Cardiol       Date:  1985-03       Impact factor: 2.882

5.  The spectrum and diagnosis of acid maltase deficiency.

Authors:  A G Engel; M R Gomez; M E Seybold; E H Lambert
Journal:  Neurology       Date:  1973-01       Impact factor: 9.910

6.  Secondary hypertrophic cardiomyopathy in infancy and childhood.

Authors:  L E Alday; E Moreyra
Journal:  Am Heart J       Date:  1984-10       Impact factor: 4.749

Review 7.  The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature.

Authors:  Hannerieke M P van den Hout; Wim Hop; Otto P van Diggelen; Jan A M Smeitink; G Peter A Smit; Bwee-Tien T Poll-The; Henk D Bakker; M Christa B Loonen; Johannis B C de Klerk; Arnold J J Reuser; Ans T van der Ploeg
Journal:  Pediatrics       Date:  2003-08       Impact factor: 7.124

Review 8.  Pompe disease in infants and children.

Authors:  Priya Sunil Kishnani; R Rodney Howell
Journal:  J Pediatr       Date:  2004-05       Impact factor: 4.406

9.  Pompe disease diagnosis and management guideline.

Authors:  Priya S Kishnani; Robert D Steiner; Deeksha Bali; Kenneth Berger; Barry J Byrne; Laura E Case; Laura Case; John F Crowley; Steven Downs; R Rodney Howell; Richard M Kravitz; Joanne Mackey; Deborah Marsden; Anna Maria Martins; David S Millington; Marc Nicolino; Gwen O'Grady; Marc C Patterson; David M Rapoport; Alfred Slonim; Carolyn T Spencer; Cynthia J Tifft; Michael S Watson
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

  9 in total
  3 in total

1.  Co-occurrence of Glycogen Storage Disease Type 2 and Congenital Myasthenic Syndrome Type 5 in a Pediatric Patient: A Case Report.

Authors:  Fawzia Al-Sharif; Mohammed F Alamer; Hussein O Taher; Raneem Y Gazzaz; Asma O AlRuwaithi; Tuleen T Miliany; Mohammed A Alrufaihi; Abdullah F Al Amer
Journal:  Cureus       Date:  2022-06-26

Review 2.  Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants.

Authors:  Jessica Kraker; Shiv Kumar Viswanathan; Ralph Knöll; Sakthivel Sadayappan
Journal:  Front Physiol       Date:  2016-10-28       Impact factor: 4.566

3.  Clinical Analysis of Algerian Patients with Pompe Disease.

Authors:  Y Sifi; M Medjroubi; R Froissart; N Taghane; K Sifi; A Benhabiles; S Lemai; S Semra; H Benmekhebi; Z Bouderda; N Abadi; A Hamri
Journal:  J Neurodegener Dis       Date:  2017-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.